billHR9126Event Wednesday, June 3, 2026Analyzed

HCBS Anti-Fraud Reporting Act of 2026

Neutral

Summary

HR9126 is an early-stage bill requiring states to report on anti-fraud measures for Medicaid home and community-based services. It authorizes no funding and imposes no direct costs on publicly traded companies. No market impact is expected at this stage.

See which stocks are affected

Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.

Already have an account? Log in

Key Takeaways

  • 1.HR9126 is a procedural reporting bill with no funding, no private-sector mandates, and no direct revenue impact on any publicly traded company.
  • 2.The bill is in early stage with low legislative momentum; no Senate companion exists.
  • 3.No tickers qualify for inclusion under the causal chain confidence gate.

Market Implications

No market implications. The bill does not affect any sector or company's revenue, costs, or competitive position. Investors should focus on legislation with direct funding or regulatory impact on public companies.

Full Analysis

On June 3, 2026, Rep. Latta (R-OH) introduced HR9126, the HCBS Anti-Fraud Reporting Act of 2026, which was referred to the House Committee on Energy and Commerce. The bill amends Section 1915(c)(2) of the Social Security Act to require states receiving Medicaid waivers for home and community-based services to report annually on detected waste, fraud, or abuse and on prevention efforts. The bill is in the earliest legislative stage—introduced and referred to committee—with no hearings, markups, or companion legislation in the Senate. It authorizes zero dollars in federal spending; it imposes a reporting requirement on states, not on private companies. The three cosponsors are all House Republicans, but none hold committee leadership positions that would accelerate passage. The legislative path requires committee consideration, House floor vote, Senate passage, and presidential action—a multi-year process with low probability in the current session. No publicly traded company is directly affected by a state-level reporting mandate. Medicaid HCBS services are delivered by a mix of state agencies, non-profits, and private providers, but the bill does not alter reimbursement rates, eligibility, or service coverage. The only potential indirect effect is a modest increase in administrative compliance costs for state Medicaid agencies, which are not publicly traded entities. No tickers meet the confidence gate of 0.65 for inclusion.

Related Presidential Actions

Executive orders & memoranda affecting the same sectors or companies

Exec OrderJun 25, 2026

Advancing Regenerative Agriculture and Strengthening American Farm Resilience

This executive order directs the EPA, USDA, and HHS to prioritize registration of alternative pesticides, expedite cumulative exposure research, and maximize funding for a regenerative agriculture pilot program, while creating public-private partnerships to expand adoption of conservation farming practices. The order specifically instructs the EPA Administrator to speed up registration actions for substances that can replace older active ingredients, and requires HHS to issue a grand prize challenge for cumulative chemical exposure evaluation technologies.

Exec OrderJun 3, 2026

Implementing Schedule Policy/Career in the Excepted Service

This executive order expands the Schedule Policy/Career excepted service category, transferring certain federal positions from competitive service to at-will employment to facilitate removal for poor performance or misconduct. It directs agency heads to petition for reclassification of policy-influencing roles, mandates performance bonus pools for these employees, and amends civil service rules to exempt them from standard adverse action procedures.

Exec OrderMay 29, 2026

Realigning United States Core Childhood Vaccine Recommendations with Best Practices from Peer, Developed Countries

This executive order directs the CDC and ACIP to review and potentially update the U.S. childhood vaccine schedule to align with recommendations from peer developed countries, which recommend fewer vaccines. It maintains insurance coverage for all currently available vaccines without cost sharing and emphasizes protecting religious liberty and parental authority.

Free — no credit card

Get the next market-moving signal before the news does

HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.

Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.

Free forever plan · No credit card · Unsubscribe in one click

Want the live terminal too? Create a free account →